Director General, DDA, Nepal visited DRAP HQ to foster mutual cooperation

Islamabad: An official delegate from Department of Drug Administration (DDA), Ministry of Health & Population, Government of Nepal under the leadership of Mr. Bharat Bhattarai, Director General, DDA visited DRAP Head quarters on Tuesday, August 23, 2022. 

Mr. Asim Rauf, CEO DRAP welcomed the Mr. Bhattarai and other senior officials from DDA and MoH, Nepal.

Directors of the Division of Pharmaceutical Evaluation & Regisatrion (PE&R), Medical Devices and Medicated Cosmetics (MDMC), and Health & OTC Products (H&OTC) demonstrated their respective presentations on the various regulatory functions of DRAP. 

The delegates showed keen interest in the journey of Pakistan toward the successful implementation of WHO/ICH Common Technical Document (CTD) format and as a result inculcate the successful registration of pharmaceutical and biological drugs in Pakistan. The delegates also praised the IT Systems established by DRAP for integrated regulatory data management in the country.

The officials of the international Health Partner, United States Pharmacopeia- Prompting Quality of Medicine Plus, from Nepal and Pakistan, were also present in these meetings.